The first high-throughput digital polymerase chain reaction method, known as BEAMING, is currently used in a wide range of applications, such as detecting KRAS mutations in the plasma circulation of colon cancer patients, and it has also been extended for the detection of methylated fragments (60–62). Here, KRAS is linked to colonic neoplasm.